Closing prices at the end of each trading day, from 28 Oct 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.
| FY2024 | FY2025 | |
|---|---|---|
| Revenue | 0.2 | n/a |
| Growth | ||
| Operating income | −10.4 | −25.2 |
| Net income | −11.5 | −28.0 |
| Growth | ||
| EPS, diluted | −0.19 | −0.39 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Operating margin | −4,168.8% | n/a |
| Net margin | −4,624.6% | n/a |
| Free cash flow margin | −3,547.6% | n/a |
| FY2024 | FY2025 | |
|---|---|---|
| Operating cash flow | −8.2 | −16.5 |
| Capital expenditure | −0.6 | −1.1 |
| Free cash flow | −8.8 | −17.5 |
| Growth |
| FY2024 | FY2025 | |
|---|---|---|
| Cash | 3.0 | 97.2 |
| Shareholders’ equity | −10.3 | 295.4 |
In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.
| Fiscal year | FY2024 31 Dec 2024 | FY2025 31 Dec 2025 |
|---|---|---|
| Operations | ||
| −8.2 | −16.5 | |
| Growth | ||
| 1.3 | 1.2 | |
| Investment | ||
| −0.6 | −1.1 | |
| calc | −8.8 | −17.5 |
| Growth | ||
| calc | −0.15 | −0.24 |
| −0.7 | −200.6 | |
| Financing | ||
| 7.3 | 311.4 | |
Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.